Literature DB >> 10611750

Phagocytosis of microorganisms by means of overshooting pseudopods: where do we stand?

M G Rittig1, B Wilske, A Krause.   

Abstract

During the endocytic uptake of particulate material such as microorganisms, the transition from the engulfment step to the internalization step of phagocytosis may be disturbed. Thus, the pseudopods flanking the particles do not close to a phagosome, but lie on top of each other. This uncoupling of pseudopod extension and phagosome formation provides useful information about the regular course of phagocytosis. Experimental models on the phenomena of coiling and overlapping phagocytosis have so far been established with legionellas, spirochetes, trypanosomatids, fungal cells, and zymosan.

Mesh:

Year:  1999        PMID: 10611750     DOI: 10.1016/s1286-4579(99)80074-4

Source DB:  PubMed          Journal:  Microbes Infect        ISSN: 1286-4579            Impact factor:   2.700


  11 in total

1.  O-antigen-deficient Francisella tularensis Live Vaccine Strain mutants are ingested via an aberrant form of looping phagocytosis and show altered kinetics of intracellular trafficking in human macrophages.

Authors:  Daniel L Clemens; Bai-Yu Lee; Marcus A Horwitz
Journal:  Infect Immun       Date:  2011-12-27       Impact factor: 3.441

2.  The effects of macrophage source on the mechanism of phagocytosis and intracellular survival of Leishmania.

Authors:  Chia-Hung Christine Hsiao; Norikiyo Ueno; Jian Q Shao; Kristin R Schroeder; Kenneth C Moore; John E Donelson; Mary E Wilson
Journal:  Microbes Infect       Date:  2011-06-30       Impact factor: 2.700

3.  Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm.

Authors:  Stephanie C Tucker; Arturo Casadevall
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

4.  Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.

Authors:  Sarah Refaie; Sandra Gagnon; Hugo Gagnon; Roxane Desjardins; François D'Anjou; Pedro D'Orléans-Juste; Xiaorong Zhu; Donald F Steiner; Nabil G Seidah; Claude Lazure; Michel Salzet; Robert Day
Journal:  J Biol Chem       Date:  2012-03-06       Impact factor: 5.157

5.  Dendritic cells phagocytose and are activated by Treponema pallidum.

Authors:  D A Bouis; T G Popova; A Takashima; M V Norgard
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

6.  Intracellular survival of Brucella spp. in human monocytes involves conventional uptake but special phagosomes.

Authors:  M G Rittig; M T Alvarez-Martinez; F Porte; J P Liautard; B Rouot
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

7.  Coiling phagocytosis of Borrelia burgdorferi by primary human macrophages is controlled by CDC42Hs and Rac1 and involves recruitment of Wiskott-Aldrich syndrome protein and Arp2/3 complex.

Authors:  S Linder; C Heimerl; V Fingerle; M Aepfelbacher; B Wilske
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

8.  The formins FMNL1 and mDia1 regulate coiling phagocytosis of Borrelia burgdorferi by primary human macrophages.

Authors:  Xenia Naj; Ann-Kathrin Hoffmann; Mirko Himmel; Stefan Linder
Journal:  Infect Immun       Date:  2013-03-04       Impact factor: 3.441

9.  Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.

Authors:  Hugo Gagnon; Sarah Refaie; Sandra Gagnon; Roxane Desjardins; Michel Salzet; Robert Day
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

10.  Small Rho GTPases and the Effector VipA Mediate the Invasion of Epithelial Cells by Filamentous Legionella pneumophila.

Authors:  Akriti Prashar; María Eugenia Ortiz; Stefanie Lucarelli; Elizabeth Barker; Zohreh Tabatabeiyazdi; Feras Shamoun; Deepa Raju; Costin Antonescu; Cyril Guyard; Mauricio R Terebiznik
Journal:  Front Cell Infect Microbiol       Date:  2018-05-03       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.